investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Scott H Kaufmann

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

William Earnshaw

University of Edinburgh

Edinburgh, United Kingdom

Scott H Kaufmann

Mayo Clinic (Rochester)

Rochester, United States

Related projects

George Thomas

The Function of rpL5 and rpL11 in Induction of p53

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Eduardo Sotomayor

Research in Transformed and Aggressive B-cell lymphomas; Personalized Medicine Initiatives

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Robert Stanley

Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Elliott D Kieff

Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation

Non-Hodgkin lymphoma

Pathology

Pascale Willem

The Coding Genome Of HIV-Associated Plasmablastic Lymphomas In South Africa

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Saro Armenian

Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Rainer F Storb

Hematopoietic Chimerism after Stem Cell Allografts

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Elaine Jaffe

Lymphoma Disease Discovery and Definition

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Scott H Kaufmann

Regulation of Death Ligand-Induced Killing

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology